[HTML][HTML] Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)

YY Qiu, J Zhang, FY Zeng, YZ Zhu - Pharmacological Research, 2023‏ - Elsevier
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease phenotypes
which start with simple steatosis and lipid accumulation in the hepatocytes-a typical …

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

X Xu, KL Poulsen, L Wu, S Liu, T Miyata… - Signal transduction and …, 2022‏ - nature.com
Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading
cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive …

Gut microbiota in overweight and obesity: crosstalk with adipose tissue

PD Cani, M Van Hul - Nature Reviews Gastroenterology & Hepatology, 2024‏ - nature.com
Overweight and obesity are characterized by excessive fat mass accumulation produced
when energy intake exceeds energy expenditure. One plausible way to control energy …

PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice

Y Wang, T Nakajima, FJ Gonzalez… - International journal of …, 2020‏ - mdpi.com
Peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ modulate lipid homeostasis.
PPARα regulates lipid metabolism in the liver, the organ that largely controls whole-body …

CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential

IR Schlaepfer, M Joshi - Endocrinology, 2020‏ - academic.oup.com
Energy homeostasis during fasting or prolonged exercise depends on mitochondrial fatty
acid oxidation (FAO). This pathway is crucial in many tissues with high energy demand and …

[HTML][HTML] Mechanisms of insulin action and insulin resistance

MC Petersen, GI Shulman - Physiological reviews, 2018‏ - journals.physiology.org
The 1921 discovery of insulin was a Big Bang from which a vast and expanding universe of
research into insulin action and resistance has issued. In the intervening century, some …

A 5: 2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

S Gallage, A Ali, JEB Avila, N Seymen, P Ramadori… - Cell Metabolism, 2024‏ - cell.com
The role and molecular mechanisms of intermittent fasting (IF) in non-alcoholic
steatohepatitis (NASH) and its transition to hepatocellular carcinoma (HCC) are unknown …

Molecular Actions of PPARα in Lipid Metabolism and Inflammation

N Bougarne, B Weyers, SJ Desmet, J Deckers… - Endocrine …, 2018‏ - academic.oup.com
Peroxisome proliferator–activated receptor α (PPAR α) is a nuclear receptor of clinical
interest as a drug target in various metabolic disorders. PPAR α also exhibits marked anti …

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors

S Francque, G Szabo, MF Abdelmalek… - Nature reviews …, 2021‏ - nature.com
The increasing epidemic of obesity worldwide is linked to serious health effects, including
increased prevalence of type 2 diabetes mellitus, cardiovascular disease and nonalcoholic …

[HTML][HTML] Fatty acid synthase: an emerging target in cancer

CW Fhu, A Ali - Molecules, 2020‏ - mdpi.com
In recent years, lipid metabolism has garnered significant attention as it provides the
necessary building blocks required to sustain tumor growth and serves as an alternative fuel …